Alpha 2.0
Login Register
» Articles » PMID: 4918156

Methotrexate Therapy for Plasmodium Vivax Malaria

Overview
Journal JAMA
Publisher American Medical Association
Specialty General Medicine
Date 1970 Oct 5
PMID 4918156
Citations 7
Authors
T W SHEEHY
H DEMPSEY
Affiliations
Soon will be listed here.
Citing Articles

Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.

Maher S, Vantaux A, Chaumeau V, Chua A, Cooper C, Andolina C Sci Rep. 2021; 11(1):19905.

PMID: 34620901 PMC: 8497498. DOI: 10.1038/s41598-021-99152-9.

The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of .

Mahmoudvand H, Kheirandish F, Mirbadie S, Kayedi M, Riabi T, Ghasemi A Iran J Parasitol. 2017; 12(3):339-347.

PMID: 28979343 PMC: 5623913.

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.

Chilengi R, Juma R, Abdallah A, Bashraheil M, Lodenyo H, Nyakundi P Malar J. 2011; 10:63.

PMID: 21410944 PMC: 3072355. DOI: 10.1186/1475-2875-10-63.

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.

Imwong M, Russell B, Suwanarusk R, Nzila A, Leimanis M, Sriprawat K J Infect Dis. 2011; 203(2):207-10.

PMID: 21288820 PMC: 3071051. DOI: 10.1093/infdis/jiq024.

Anticancer agents against malaria: time to revisit?.

Nzila A, Okombo J, Becker R, Chilengi R, Lang T, Niehues T Trends Parasitol. 2010; 26(3):125-9.

PMID: 20056487 PMC: 2927876. DOI: 10.1016/j.pt.2009.12.002.